Effects of pre-meal versus post-meal administration of miglitol on plasma glucagon-like peptide-1 and glucosedependent insulinotropic polypeptide levels in healthy men-Reference-Cited by-同舟云学术

Effects of pre-meal versus post-meal administration of miglitol on plasma glucagon-like peptide-1 and glucosedependent insulinotropic polypeptide levels in healthy men

Published:2010 Issue:8 Volume:57 Page:673-677
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Aoki Kazutaka¹²,Miyazaki Takashi²,Nagakura Jo²,Orime Kazuki²,Togashi Yu²,Terauchi Yasuo²

Affiliation:

1. Yokosuka Kyousai Hospital, Yokosuka, Japan

2. Department of Endocrinology and Metabolism, Yokohama City University Graduate School of Medicine, Yokohama, Japan

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.jstage.jst.go.jp/article/endocrj/57/8/57_K10E-064/_pdf

Reference15 articles.

1. 1. Macfarlane DP, Paterson KR, Fisher M (2007) Oral antidiabetic agents as cardiovascular drugs. Diabetes Obes Metab 9: 23-30.

2. 2. Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B (2006) Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 29:1963-1972.

3. Divided-Dose Administration of Miglitol just before and 15 Minutes after the Start of a Meal Smoothes Postprandial Plasma Glucose Excursions and Serum Insulin Responses in Healthy Men

4. Administration of miglitol until 30min after the start of a meal is effective in type 2 diabetic patients

5. Comparison of pre- vs. postmeal administration of miglitol for 3 months in type 2 diabetic patients

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationships among Postprandial Plasma Active GLP-1 and GIP Excursions, Skeletal Muscle Mass, and Body Fat Mass in Patients with Type 2 Diabetes Treated with Either Miglitol, Sitagliptin, or Their Combination: A Secondary Analysis of the MASTER Study;Journal of Clinical Medicine;2023-04-24

2. Pyrazole scaffold‐based derivatives: A glimpse of α‐glucosidase inhibitory activity, SAR, and route of synthesis;Archiv der Pharmazie;2023-01-08

3. The Molecular Determinants of Glucagon-like Peptide Secretion by the Intestinal L cell;Endocrinology;2022-09-26

Add-On Therapy with DPP-4 Inhibitors May Improve Renal Function Decline in α-Glucosidase Inhibitor and Metformin Users: A Retrospective Observational Study

;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2020-10

5. Canagliflozin Increases Postprandial Total Glucagon-Like Peptide 1 Levels in the Absence of α-Glucosidase Inhibitor Therapy in Patients with Type 2 Diabetes: A Single-Arm, Non-randomized, Open-Label Study;Diabetes Therapy;2019-09-10